Ryan Van Laar
Ryan Van Laar
Geneseq Biosciences
Verified email at - Homepage
Cited by
Cited by
Identification and functional significance of genes regulated by structurally different histone deacetylase inhibitors
MJ Peart, GK Smyth, RK Van Laar, DD Bowtell, VM Richon, PA Marks, ...
Proceedings of the National Academy of Sciences 102 (10), 3697-3702, 2005
Options available—from start to finish—for obtaining data from DNA microarrays II
AJ Holloway, RK Van Laar, RW Tothill, DDL Bowtell
Nature genetics 32 (4), 481-489, 2002
Empirical array quality weights in the analysis of microarray data
ME Ritchie, D Diyagama, J Neilson, R van Laar, A Dobrovic, A Holloway, ...
BMC bioinformatics 7, 1-16, 2006
Genomic analysis of a spontaneous model of breast cancer metastasis to bone reveals a role for the extracellular matrix
BL Eckhardt, BS Parker, RK Van Laar, CM Restall, AL Natoli, MD Tavaria, ...
Molecular Cancer Research 3 (1), 1-13, 2005
Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma.
AM Glas, L Knoops, L Delahaye, MJ Kersten, RE Kibbelaar, LA Wessels, ...
An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin
RW Tothill, A Kowalczyk, D Rischin, A Bousioutas, I Haviv, RK van Laar, ...
Cancer Research 65 (10), 4031-4040, 2005
Gene expression profiling to identify the histogenetic origin of metastatic adenocarcinomas of unknown primary
HM Horlings, RK van Laar, JM Kerst, HH Helgason, J Wesseling, ...
J Clin Oncol 26 (27), 4435-4441, 2008
Effect of ASCO/CAP guidelines for determining ER status on molecular subtype
B Deyarmin, JL Kane, AL Valente, R van Laar, C Gallagher, CD Shriver, ...
Annals of surgical oncology 20, 87-93, 2013
Gene expression profiling may improve diagnosis in patients with carcinoma of unknown primary
J Bridgewater, R Van Laar, A Floore, L Van'T Veer
British journal of cancer 98 (8), 1425-1430, 2008
Comparison of gene expression profiles predicting progression in breast cancer patients treated with tamoxifen
M Kok, SC Linn, RK Van Laar, MPHM Jansen, TM Van den Berg, ...
Breast cancer research and treatment 113, 275-283, 2009
Development and validation of a plasma-based melanoma biomarker suitable for clinical use
R Van Laar, M Lincoln, B Van Laar
British journal of cancer 118 (6), 857-866, 2018
Translating a gene expression signature for multiple myeloma prognosis into a robust high-throughput assay for clinical use
R Van Laar, R Flinchum, N Brown, J Ramsey, S Riccitelli, C Heuck, ...
BMC medical genomics 7, 1-13, 2014
Implementation of a novel microarray‐based diagnostic test for cancer of unknown primary
RK van Laar, XJ Ma, D de Jong, D Wehkamp, AN Floore, MO Warmoes, ...
International journal of cancer 125 (6), 1390-1397, 2009
System and method for classification of patients
R Van Laar
US Patent 8,999,648, 2015
System and method for classification of patients
R Van Laar
US Patent 8,999,648, 2015
System and method for classification of patients
R Van Laar
US Patent 8,999,648, 2015
Genomic signatures for predicting survival and adjuvant chemotherapy benefit in patients with non-small-cell lung cancer
RK Van Laar
BMC medical genomics 5, 1-12, 2012
Location of, immunogenicity of and relationships between neutralization epitopes on the attachment protein (G) of Hendra virus
JR White, V Boyd, GS Crameri, CJ Duch, RK van Laar, LF Wang, ...
Journal of general virology 86 (10), 2839-2848, 2005
Gene expression differences in adipose tissue associated with breast tumorigenesis
LA Sturtz, B Deyarmin, R van Laar, W Yarina, CD Shriver, RE Ellsworth
Adipocyte 3 (2), 107-114, 2014
Recreational music-making alters gene expression pathways in patients with coronary heart disease
B Bittman, DT Croft Jr, J Brinker, R van Laar, MN Vernalis, DL Ellsworth
Medical science monitor: international medical journal of experimental and …, 2013
The system can't perform the operation now. Try again later.
Articles 1–20